|
Volumn 30, Issue 5, 1998, Pages 1778-1779
|
Antibody therapy in steroid-resistant rejection
a,c a b a b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
OKT 3;
THYMOCYTE ANTIBODY;
AGED;
CANCER INCIDENCE;
CHILL;
CONFERENCE PAPER;
DYSPNEA;
FEMALE;
FEVER;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEADACHE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
HYPOTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
IMMUNOTHERAPY;
MALE;
NAUSEA;
PRIORITY JOURNAL;
STEROID THERAPY;
ANTILYMPHOCYTE SERUM;
CHI-SQUARE DISTRIBUTION;
CYCLOSPORINE;
DRUG RESISTANCE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MUROMONAB-CD3;
RETROSPECTIVE STUDIES;
STEROIDS;
SURVIVAL RATE;
TIME FACTORS;
|
EID: 0031710167
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00428-X Document Type: Conference Paper |
Times cited : (4)
|
References (7)
|